Vitamin D in relation to myocardial structure and function after eight years of follow-up: The Hoorn Study

Annals of Nutrition and Metabolism

Volumn 60, Issue 1, 2012, Pages 69-77

  Van Ballegooijen, A J ^a   Snijder, M B ^b   Visser, M ^a,c   Van Den Hurk, K ^c   Kamp, O ^c   Dekker, J M ^c   Nijpels, G ^c   Stehouwer, C D A ^d   Henry, R M A ^d   Paulus, W J ^c   Brouwer, I A ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Elderly; Epidemiology; Myocardial function; Myocardial structure; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HUMAN; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D 2; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIFEDIOL; COMORBIDITY; DIASTOLE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LIPIDS; MALE; MIDDLE AGED; MYOCARDIUM; NETHERLANDS; PARATHYROID HORMONE; RISK FACTORS; SOCIOECONOMIC FACTORS; SYSTOLE; VITAMIN D DEFICIENCY;

EID: 84856835454     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000336173     Document Type: Article

References (37)

1. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174-1180. (Pubitemid 351831400)
3. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
4. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73-81.
5. Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, Choi EJ, Chang YS, Bang BK: Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 2006; 102:c21-c29.
6. Mancuso P, Rahman A, Hershey SD, Dandu L, Nibbelink KA, Simpson RU: 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failureprone (cp/+) rats independent of changes in serum leptin. J Cardiovasc Pharmacol 2008;51: 559-564.
7. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU: Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008; 149: 558-564. (Pubitemid 351159356)
8. Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959.
9. Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, Marz W: Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010; 31: 1591-1598.
10. Hagstrom E, Ingelsson E, Sundstrom J, Hellman P, Larsson TE, Berglund L, Melhus H, Held C, Michaelsson K, Lind L, Arnlov J: Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010; 12: 1186-1192.
11. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ: Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 1995; 18: 1270-1273.
12. Henry RM, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, van Eijck R, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn Study. Diabetes Care 2004; 27: 522-529. (Pubitemid 38174082)
13. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Lips P: Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 2007; 85: 755-761. (Pubitemid 46393507)
14. Prentice A, Goldberg GR, Schoenmakers I: Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008; 88:500S-506S.
15. van den Hurk K, Alssema M, Kamp O, Henry RM, Stehouwer CD, Diamant M, Boomsma F, Heine RJ, Nijpels G, Paulus WJ, Dekker JM: Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail 2010; 12: 958-965.
16. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42:S1-S201.
17. Bolland MJ, Chiu WW, Davidson JS, Grey A, Bacon C, Gamble GD, Reid IR: The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency. NZ Med J 2008; 121: 63-74.
18. Scragg RK, Camargo CA Jr, Simpson RU: Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 2010; 105: 122-128.
19. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927-3935.
20. Ameri P, Ronco D, Casu M, Denegri A, Bovio M, Menoni S, Ferone D, Murialdo G: High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010; 20: 633-640.
21. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ: Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997; 103: 197-207. (Pubitemid 27413402)
22. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-759. (Pubitemid 44713136)
23. Pilz S, Henry RM, Snijder MB, van Dam RM, Nijpels G, Stehouwer CD, Kamp O, Tomaschitz A, Pieber TR, Dekker JM: Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study. J Endocrinol Invest 2010; 33:612-617.
24. Achinger SG, Ayus JC: The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005; 95:S37-S42. (Pubitemid 43361555)
25. Murayama A, Takeyama K, Kitanaka S, Kodera Y, Kawaguchi Y, Hosoya T, Kato S: Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999; 140: 2224-2231. (Pubitemid 30636463)
26. McGonigle RJ, Fowler MB, Timmis AB, Weston MJ, Parsons V: Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone. Nephron 1984; 36: 94-100. (Pubitemid 14212640)
27. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71: 31-38. (Pubitemid 44967731)
28. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD: Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011; 6: 50-62.
29. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S: Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58: 374-382.
30. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 7:CD007470.
31. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, Marz W: Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 54:1103-1113.
32. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
33. Saleh FN, Schirmer H, Sundsfjord J, Jorde R: Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003; 24: 2054-2060. (Pubitemid 37420453)
34. Nasri H, Baradaran A: Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Bratisl Lek Listy 2004; 105:368-373.
35. Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttmann RD: Left ventricular hypertrophy in end-stage renal disease. Nephron 1988; 48: 107-115.
36. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G: Left ventricular hypertrophy in primary hyperparathyroidism: effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999;50: 321-328. (Pubitemid 29166711)
37. Tastan I, Schreckenberg R, Mufti S, Abdallah Y, Piper HM, Schluter KD: Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way. Cardiovasc Res 2009; 82: 77-83.